Table 2.
Response to treatments and adverse effects observed in patients in the 2 treatment groups.
| Variables | Standard regimen | New regimen | P value |
|---|---|---|---|
| Area of hair regrowth, n (%) | |||
| no hair regrowth | 3(13) | 2 (12.5) | 0.99 |
| 1-25% | 2 (8.6) | 2 (12.5) | |
| 26-50% | 2 (8.6) | 1 (6.2) | |
| 51-75% | 4 (17.7) | 3 (18.9) | |
| 76-99% | 5 (21.7) | 1 (6.2) | |
| 100% | 7 (30.4) | 7 (43.7) | |
| Mean duration to initial response (week) | 14.2±3.9 | 10.5±2.6 | 0.002* |
| Mean duration to >75% hair regrowth (week)# | 29.2±6.5 | 24.3±4.2 | 0.01* |
| Relapse, n (%) | 5 (21.7) | 4(25) | 0.81 |
| Median duration to relapse (week) | 14 (8-23) | 11 (6-18) | 0.62 |
| Adverse effects, n (%) | |||
| Blister formation | 1 (4.3) | 1 (6.2) | 0.9 |
| Widespread eczema | 3(13) | 6 (37.4) | |
| Dyspigmentation | 1 (4.3) | 2 (12.5) | |
| Lymphadenopathy | 7(30) | 8(50) |
*Statistically significant
#data collected from patients with >75% hair regrowth.